Harvard Bio Plans to Tap Academic Database To Help Grow Sales; Sees Small Acquisitions | GenomeWeb

Harvard Bioscience, reporting a small decline in second-quarter revenues, said it would exploit its database of more than 150,000 academics in an effort to increase sales.

The firm also disclosed that it has engaged investment banking firm Thomas Weisel Partners to help it find a buyer for the capital equipment segment, which includes the struggling Genomic Solutions business. The company said it would use proceeds from the sale to pay down a $15.2 million debt facility and finance tuck-in acquisitions for the apparatus business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.